Article
Assessment of biochemical recurrence of prostate cancer (Review)
4 Oct 2019
Abstract excerpt
The assessment of the risk of biochemical recurrence (BCR) is critical in the management of males with prostate cancer (PC). Over the past decades, a comprehensive effort has been focusing on improving risk stratification; a variety of models have been constructed using PC‑associated pathological features and molecular alterations occurring at the genome, protein and RNA level. Alterations in RNA expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
